THOMPSON VIRGIL 4
4 · Processa Pharmaceuticals, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
THOMPSON VIRGIL
Director
Transactions
- Award
Restricted Stock
2023-01-01+30,000→ 30,000 totalExercise: $0.00→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2022-12-31+18,208→ 100,213 total(indirect: By Trust)
Holdings
- 16,693
Common Stock
Footnotes (2)
- [F1]Vesting of time-based restricted shares.
- [F2]The Restricted Stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.